Last reviewed · How we verify
NCT04084600
Effects of Manual Therapy on Chronic Pain and Functionality of Breast Cancer Survivors
NA trial testing Kinesiotherapy Protocol in Breast Cancer in 10 participants. Terminated before completion.
27 February 2020
Quick facts
| Lead sponsor | University of the State of Santa Catarina |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 1 November 2019 |
| Primary completion | 27 February 2020 |
| Estimated completion | 27 February 2020 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Kinesiotherapy Protocol
- Manual Therapy Protocol
- Traditional Massage
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
Sponsor
University of the State of Santa Catarina
Who can join
18 and older, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
the aim of this study is to verify whether manual therapy associated with kinesiotherapy is more effective than kinesiotherapy alone in the treatment of chronic pain and upper limb dysfunction in women surviving cancer of mama. It is a randomized controlled double blind clinical trial (evaluator and patient), parallel in two groups (Intervention Group and Sham Group). The intervention will last 6 weeks and chronic pain and upper limb functionality will be evaluated. Both groups will undergo a kinesiotherapy program once a week for 6 consecutive weeks. Also, participants in the intervention group will receive, once a week, a manual therapy protocol, while participants in the Sham group will receive traditional massage. Manual therapy associated with kinesiotherapy is expected to yield superior results to the isolated kinesiotherapy in chronic pain and upper limb functionality.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04084600
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other University of the State of Santa Catarina trials
Trials by the same sponsor.
- NCT07469280 — High-Intensity Progressive Inspiratory Muscle Training in Class III Obesity and Obstructive Sleep Apnea · NA · not yet recruiting
- NCT06485063 — Myofascial Reorganization on Performance, and Biomechanical, Viscoelastic, and Thermographic Properties of Athletes · NA · recruiting
- NCT06348186 — Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19 · NA · recruiting
- NCT05760664 — Exercises Directed To Dynamic Stiffness Of The Thoracolumbar Region And Performance Of Amateur Runners · NA · recruiting
- NCT05742542 — The Effects of High vs. Low Time Spent Near VO2max During Two Work-matched High Intensity Interval Training. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04084600 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of the State of Santa Catarina
- Last refreshed: 26 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04084600.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing